These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2228828)

  • 21. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR
    Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of quinolones against mycobacteria.
    Jacobs MR
    Drugs; 1999; 58 Suppl 2():19-22. PubMed ID: 10553700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.
    Heifets LB; Lindholm-Levy PJ
    Antimicrob Agents Chemother; 1990 May; 34(5):770-4. PubMed ID: 2113793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H; Sato K; Tomioka H; Dekio S
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I; Verbist L; Vandepitte J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
    Khan MY; Dizon M; Kiel FW
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1409-10. PubMed ID: 2802568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
    Guillemin I; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2084-8. PubMed ID: 9687411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
    Karak K; De PK
    Indian J Med Res; 1995 Apr; 101():147-9. PubMed ID: 7751043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
    Tomioka H; Saito H; Sato K
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
    Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
    J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Sirgel FA; Venter A; Heilmann HD
    J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of the susceptibility in vitro of 54 isolates of Mycobacterium fortuitum against three fluoroquinolones using two methods.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Apr; 7(2):109-13. PubMed ID: 7666115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC; Foleno BD; Fu KP
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.